TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $6,725,000 | -42.9% | 353,983 | 0.0% | 0.04% | -46.2% |
| Q3 2021 | $11,780,000 | -14.2% | 353,983 | 0.0% | 0.08% | -14.9% |
| Q2 2021 | $13,731,000 | -72.8% | 353,983 | -65.0% | 0.09% | -77.6% |
| Q1 2021 | $50,480,000 | -3.9% | 1,010,227 | 0.0% | 0.42% | +1.0% |
| Q4 2020 | $52,554,000 | +30.8% | 1,010,227 | -32.7% | 0.42% | +10.3% |
| Q3 2020 | $40,178,000 | +33.3% | 1,501,489 | -2.9% | 0.38% | +18.6% |
| Q2 2020 | $30,138,000 | +189.3% | 1,547,071 | +61.2% | 0.32% | +176.5% |
| Q1 2020 | $10,417,000 | -2.2% | 959,973 | +0.0% | 0.12% | +0.9% |
| Q4 2019 | $10,655,000 | +78.8% | 959,916 | +38.7% | 0.11% | +54.1% |
| Q2 2019 | $5,960,000 | +7.1% | 692,000 | 0.0% | 0.07% | +4.2% |
| Q1 2019 | $5,564,000 | +96.1% | 692,000 | 0.0% | 0.07% | +61.4% |
| Q4 2018 | $2,837,000 | -26.8% | 692,000 | 0.0% | 0.04% | -15.4% |
| Q3 2018 | $3,875,000 | -30.7% | 692,000 | +62.8% | 0.05% | -40.9% |
| Q2 2018 | $5,589,000 | +9.3% | 425,000 | +18.1% | 0.09% | +1.1% |
| Q1 2018 | $5,112,000 | +130.9% | 360,000 | +33.3% | 0.09% | +128.9% |
| Q4 2017 | $2,214,000 | -15.1% | 270,000 | +22.7% | 0.04% | -17.4% |
| Q3 2017 | $2,607,000 | +17.9% | 220,000 | 0.0% | 0.05% | +9.5% |
| Q2 2017 | $2,211,000 | -39.8% | 220,000 | -30.2% | 0.04% | -40.8% |
| Q1 2017 | $3,670,000 | +250.9% | 315,000 | +40.0% | 0.07% | +195.8% |
| Q4 2016 | $1,046,000 | -20.5% | 225,000 | +32.4% | 0.02% | -25.0% |
| Q3 2016 | $1,316,000 | +27.8% | 170,000 | 0.0% | 0.03% | +18.5% |
| Q2 2016 | $1,030,000 | -41.3% | 170,000 | -17.9% | 0.03% | -38.6% |
| Q1 2016 | $1,754,000 | -37.8% | 207,000 | -12.4% | 0.04% | -41.3% |
| Q4 2015 | $2,818,000 | +7.0% | 236,200 | -9.6% | 0.08% | +15.4% |
| Q3 2015 | $2,633,000 | -47.1% | 261,200 | -12.9% | 0.06% | -37.5% |
| Q2 2015 | $4,977,000 | -2.6% | 300,000 | -9.1% | 0.10% | +1.0% |
| Q1 2015 | $5,110,000 | -15.1% | 330,000 | -13.2% | 0.10% | -18.3% |
| Q4 2014 | $6,019,000 | – | 380,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |